Novel Technologies for Understanding Metabolomic Communications between Host and Microbiota
Webinar Presentation by Alex Buko, Vice President Business and Product Development at Human Metabolome Technologies America.
Webinar Presentation by Alex Buko, Vice President Business and Product Development at Human Metabolome Technologies America.
UT Southwestern researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice. The study published this week by the Journal of Experimental Medicine could lay the […]
LUCA Biologics, a biotechnology company co-founded by Dr. Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women’s health. Ravel will serve as LUCA’s Chief Scientist. The company’s first […]
A new study published in the peer-reviewed journal Hepatology Communications finds that the multi-strain De Simone Formulation probiotic medical food may help in the dietary management of dysbiosis associated with cirrhosis by improving cognitive function, […]
The Microbiome Congress in May in Rotterdam brought together three conferences: the 6th Microbiome forum, the 3rd Probiotics Congress and the Skin Microbiome and Cosmeceuticals congress, running in parallel. For this reason this report can’t […]
Genetics has a greater impact on the microbiome than maternal birth environment, at least in mice, according to a study published this week in Applied and Environmental Microbiology. Vaginal birth, known to transfer microbiota to […]
A research team led by Tufts University engineers has developed a 3D printed pill that samples bacteria found in the gut — known as the microbiome — as it passes through the gastrointestinal tract (GI). […]
Getting up close – and a little dirty – with farm animals just might help us fend off illness, say researchers who’ve further demonstrated the benefits of early exposure to a wide variety of environmental […]
Ilya Pharma developing advanced biologics announced that a first in human trial for its lead candidate ILP100 has been approved by the Swedish Medical Products Agency. ILP100 is based on genetically engineered lactic acid bacteria […]
Pherecydes Pharma and BIOASTER, the French Technology Research Institute (TRI) for Microbiology and Infectious Diseases, announced the signing of a collaboration agreement. This project, called PhagUTI, is a unique opportunity for the partners to capitalize […]
Chardan Healthcare Acquisition Corp. (NYSE: CHAC, “CHAC”), a special purpose acquisition company (“SPAC”) sponsored by affiliates of Chardan Capital Markets LLC (“Chardan”), announced today that it has entered into a definitive agreement for a business […]